Cathie's Ark Logo
Recursion Pharmaceuticals Inc Logo

ARKG Holdings of Recursion Pharmaceuticals (RXRX) - Updated Daily

Bioinformatics
Date
Direction
Shares
Fund Weight
Fund
May 10, 2023
BUY147.832k0.0424%ARKG
May 9, 2023
BUY189.682k0.0554%ARKG
May 8, 2023
BUY188.297k0.0548%ARKG
March 9, 2023
BUY52.897k0.0215%ARKG
March 8, 2023
BUY2.759k0.0011%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
1.68%$1.58b
🏋🏿‍♂️Weight Rank In ARKG🌏Country
23🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
50$19.22
🎫ARK Ownership Percent
2.14%
Description
recursion pharmaceuticals has developed a powerful drug discovery platform involving millions of rapid, automated experiments and analysis to discover new therapeutics. our platform has resulted in the massive parallelization of drug discovery. we have deployed this platform in pursuit of drugs for the treatment of rare genetic diseases. we partner or out-license these leads to major pharmaceutical companies early in development. our horizontal business model focused on discovery accelerates our impact and reduces our costs by avoiding slow and costly in-house development, and allows us to spread risk across many new therapeutic opportunities.
Website
recursionpharma.com

Other ETFs That Hold RXRX

Ticker
NameWeight
ARKGARK Genomic Revolution ETF1.4%
XBISPDR® S&P Biotech ETF0.5%
IBBiShares Biotechnology ETF0.06%
LABUS&P Biotech Bull 3X Shares ETF0.056%

Research Notes and Commentary for RXRX

No Research Notes Found for RXRX